Community
TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
May 11, 2026
2 min read
47

The after-hours trading session saw significant volatility driven by individual company earnings reports and corporate announcements. Tech and biotech sectors showed notable movement, with companies like Harmonic and Plug Power posting strong gains, while Hims & Hers Health faced a decline following its quarterly results.
Several companies reported financial results that heavily influenced their stock prices. Harmonic (HLIT) surged 8% after delivering a substantial beat on both revenue and earnings per share. Similarly, Plug Power (PLUG) gained 5.7% by outperforming Wall Street's expectations. In contrast, Hims & Hers Health (HIMS) fell 7% due to missing analyst estimates on its Q1 earnings and revenue.
Archer Aviation (ACHR) rose 4% after becoming the first to complete a key phase of the FAA’s certification process for its eVTOL aircraft. AbCellera Biologics (ABCL) also climbed 6% on a narrower-than-expected loss and positive clinical trial results for its menopause treatment.
Beazer Homes (BZH) dropped 6% after its board rejected a buyout bid it deemed undervalued the company. The most significant drop was seen in Power Solutions International (PSIX), which plummeted 35% following a disappointing earnings report that missed analyst targets.
The after-hours session was characterized by company-specific news rather than broad market trends. Investors are closely monitoring earnings reports and strategic corporate updates as key drivers of stock performance. The varied results indicate a selective market environment.
Q: Why did Harmonic (HLIT) stock increase significantly?
A: HLIT stock climbed 8% after the company reported first-quarter earnings and revenue that far surpassed analyst consensus estimates.
Q: What caused the drop in Hims & Hers Health (HIMS) shares?
A: HIMS shares fell 7% after the company reported Q1 earnings per share and revenue that both missed analyst expectations.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles